Masimo Corp. (NASDAQ:MASI) shares hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $53.80 and last traded at $53.18, with a volume of 118,439 shares. The stock had previously closed at $52.67.

Several research analysts recently issued reports on MASI shares. Roth Capital increased their price objective on Masimo Corp. from $40.00 to $50.00 and gave the stock a “buy” rating in a research note on Thursday, May 5th. Piper Jaffray Cos. raised Masimo Corp. from a “neutral” rating to an “overweight” rating and increased their price objective for the stock from $43.00 to $52.00 in a research note on Thursday, May 5th. Wedbush increased their price objective on Masimo Corp. from $51.00 to $57.00 and gave the stock an “outperform” rating in a research note on Thursday, May 5th. Zacks Investment Research raised Masimo Corp. from a “hold” rating to a “buy” rating and set a $51.00 price objective on the stock in a research note on Friday, May 6th. Finally, Raymond James Financial Inc. lowered Masimo Corp. from a “strong-buy” rating to an “outperform” rating in a report on Wednesday, June 1st. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Masimo Corp. presently has an average rating of “Buy” and a consensus price target of $50.80.

The company’s 50 day moving average is $51.29 and its 200 day moving average is $43.03. The firm has a market capitalization of $2.58 billion and a PE ratio of 31.10.

Masimo Corp. (NASDAQ:MASI) last released its quarterly earnings results on Wednesday, May 4th. The company reported $0.53 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.43 by $0.10. The firm had revenue of $171.20 million for the quarter, compared to analysts’ expectations of $165.25 million. The firm’s quarterly revenue was up 10.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.41 EPS. Equities research analysts expect that Masimo Corp. will post $1.83 earnings per share for the current year.

In other news, insider Rick Fishel sold 25,000 shares of Masimo Corp. stock in a transaction that occurred on Wednesday, May 25th. The shares were sold at an average price of $49.85, for a total transaction of $1,246,250.00. Following the sale, the insider now owns 52,022 shares of the company’s stock, valued at approximately $2,593,296.70. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Paul Jansen sold 10,000 shares of Masimo Corp. stock in a transaction that occurred on Thursday, April 28th. The shares were sold at an average price of $44.88, for a total transaction of $448,800.00. Following the sale, the executive vice president now directly owns 10,000 shares in the company, valued at approximately $448,800. The disclosure for this sale can be found here.

Other hedge funds have recently added to or reduced their stakes in the company. Russell Frank Co raised its stake in Masimo Corp. by 201.1% in the fourth quarter. Russell Frank Co now owns 116,873 shares of the company’s stock valued at $4,946,000 after buying an additional 78,064 shares during the last quarter. Nationwide Fund Advisors raised its stake in Masimo Corp. by 20.3% in the fourth quarter. Nationwide Fund Advisors now owns 203,400 shares of the company’s stock valued at $8,443,000 after buying an additional 34,271 shares during the last quarter. California State Teachers Retirement System raised its stake in Masimo Corp. by 1.6% in the fourth quarter. California State Teachers Retirement System now owns 81,062 shares of the company’s stock valued at $3,365,000 after buying an additional 1,288 shares during the last quarter. Numeric Investors LLC purchased a new stake in Masimo Corp. during the fourth quarter valued at approximately $1,050,000. Finally, Rhumbline Advisers raised its stake in Masimo Corp. by 7.6% in the fourth quarter. Rhumbline Advisers now owns 54,693 shares of the company’s stock valued at $2,270,000 after buying an additional 3,845 shares during the last quarter.

Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.